杏吧原创

After decades of hope and hype, this year saw the coming of age of the 鈥渕agic
bullet鈥� approach to cancer. Glivec, the first 鈥渟mall molecule鈥� cancer therapy,
got the fastest US approval of any cancer drug in history for treating a rare
leukaemia. It proved successful against a stomach cancer, too, and to complete a
busy year it has been granted a British licence. Glivec alone won鈥檛 be a miracle
cure for cancer. But with at least six other Glivec-like drugs in trials, each
aimed at a different kind of cancer, it won鈥檛 be long before doctors can tailor
treatments to each patient.